+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Osmotica Pharmaceuticals Plc To Provide Second Quarter 2020 Business And Financial Update And Presentation On Upneeq On August 11 2020 is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Osmotica Pharmaceuticals Plc To Provide Second Quarter 2020 Business And Financial Update And Presentation On Upneeq On August 11 2020 | RobinsPost News & Noticias

Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4


DUBLIN, Ireland, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq ... March 4, 2024, to provide a corporate update and discuss the Company's financial results for the fourth ... Read More

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024


BOSTON and LONDON, April 22, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage ... which does not form part of this release. This press release contains ... Read More

Avadel Pharmaceuticals plc (AVDL)


DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc ... August 9, 2023, to provide a corporate update and discuss the Company's financial results for the second quarter ... Read More

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024


SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31 ... Read More

Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results


Participants may access the conference call via webcast on the Investor page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. An archived ... Read More

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights


LONDON, UK / ACCESSWIRE / March 28, 2024 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company ... the share capital of the Company under the Financial Conduct Authority's ... Read More

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update


today announced that it has scheduled its first quarter 2024 financial results and corporate update for Thursday, May 2, 2024. The schedule for the press release and conference call/webcast are as ... Read More

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023


Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported recent business highlights and financial results for the fourth quarter and full-year ended ... Read More

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update


March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals ... today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a business update. Read More

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update


Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the fiscal year ended December 31, 2023 and provided a business ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus